Bone Morphogenetic Protein 5 (BMP5) (Middle Region) Peptide
BMP5
Reactivity: Human
Host: Synthetic
WB
-
- Target See all BMP5 products
- BMP5 (Bone Morphogenetic Protein 5 (BMP5))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Western Blotting (WB)
- Sequence
- QGPQSKQPFM VAFFKASEVL LRSVRAANKR KNQNRNKSSS HQDSSRMSSV
-
Bone Morphogenetic Protein 5 (BMP5) (AA 317-454) peptide
BMP5 Reactivity: Human Host: Escherichia coli (E. coli) SDS
-
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BMP5 (Bone Morphogenetic Protein 5 (BMP5))
- Synonyms
- bmp5l Peptide, hm:zehl0669 Peptide, zehl0669 Peptide, zgc:64230 Peptide, BMP5 Peptide, AU023399 Peptide, se Peptide, bone morphogenetic protein 5 Peptide, bmp5 Peptide, BMP5 Peptide, LOC100539495 Peptide, Bmp5 Peptide
- Background
-
This gene encodes a member of the bone morphogenetic protein family which is part of the transforming growth factor-beta superfamily. The superfamily includes large families of growth and differentiation factors. Bone morphogenetic proteins were originally identified by an ability of demineralized bone extract to induce endochondral osteogenesis in vivo in an extraskeletal site. These proteins are synthesized as prepropeptides, cleaved, and then processed into dimeric proteins. This protein may act as an important signaling molecule within the trabecular meshwork and optic nerve head, and may play a potential role in glaucoma pathogenesis. This gene is differentially regulated during the formation of various tumors.
Protein Size: 167 - Gene ID
- 653
- NCBI Accession
- NM_021073, NP_066551
- UniProt
- P22003
-
You are here:
